Ocuphire Pharma Inc Ordinary Shares OCUP 深 滬
已收盤 10-23 16:00:00 美东时间
1.17
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 1.17
- 總市值 2648.60万
- 52周最高 3.3994
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.0715
- 委 比 0.00%
- 總股本 2263.76万
- 歷史最高 23.08
- 量 比 0
- 振 幅 0.00%
- 歷史最低 1.0715
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Ocuphire Pharma Merges with Opus Genetics, Renamed Opus Genetics
Ocuphire Pharma ( ($OCUP) ) just unveiled an update. Ocuphire Pharma has acquir...
2024-10-23 05:31
Analysts Offer Insights on Healthcare Companies: Chimerix (CMRX) and Ocuphire Pharma (OCUP)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
2024-08-21 17:06
Ocuphire Announces the US Commercial Launch of RYZUMVl (Phentolamine Ophthalmic Solution 0.75%) by its Partner Viatris
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of unmet needs of patients with retinal and refractive eye disorders, today
2024-04-01 19:17
Ocuphire Pharma Engages Investors with Presentation Update
Ocuphire Pharma (OCUP) just unveiled an announcement. Ocuphire Pharma, Inc. is ...
2024-03-28 04:44
Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
2024-03-26 19:37
Ocuphire Pharma Strengthens Leadership Team with Key Appointments; Nirav Jhaveri, C.F.A, M.B.A. Appointed As Chief Financial Officer
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial OfficerFARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ocuphire
2024-02-14 21:17
A Look Into Healthcare Sector Value Stocks
Understanding Value Stocks A value stock is traditionally defined in terms of h...
2023-11-20 22:44
Recap: Ocuphire Pharma Q3 Earnings
Ocuphire Pharma (NASDAQ:OCUP) reported its Q3 earnings results on Monday, Novem...
2023-11-13 22:10
Ocuphire Pharma Announces Appointment Of George Magrath, M.D., M.B.A., M.S., As Chief Executive Officer And Director
Ocuphire Pharma, Inc. (NASDAQ:OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders,
2023-11-01 20:24
